PTCT

PTC Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$67.77

Market Cap

$5.61B

Beta

0.56

P/E

9.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+114.51%

EPS Growth (YoY)+263.64%

Revenue CAGR 3Y+35.30%

P/E Ratio9.0

PEG Ratio0.03

FCF Yield+12.46%

Debt / Equity0.00

Interest Coverage5.6x

No credit card required

Already have an account? Sign in to view the full analysis for PTCT.